Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030
The veterinary reference laboratory market is forecasted to grow from USD 4.75 million in 2025 to USD 6.46 million by 2030, recording a CAGR of 6.3%. The increasing prevalence of zoonotic and chronic animal diseases, rising companion animal ownership, and the growing emphasis on preventive healthcare primarily drive market expansion. The rising demand for advanced diagnostic testing, including molecular diagnostics, immunodiagnostics, and clinical chemistry, has accelerated the establishment of high-throughput reference laboratories in both developed and emerging regions. Moreover, technological advancements in automation, AI-based image analysis, and molecular testing are enabling faster turnaround times and improved diagnostic accuracy, fostering greater trust among veterinarians and pet owners.
At the same time, the increasing integration of diagnostic services with digital platforms and laboratory information management systems (LIMS) is streamlining workflows, enhancing sample traceability, and enabling remote access to test results. The rising focus on early disease detection and companion animal wellness programs further supports test adoption, while expanding veterinary corporatization and partnerships between clinics and reference labs are driving consistent sample inflows. However, the market faces challenges such as high operational and testing costs, a shortage of skilled laboratory professionals, and stringent regulatory standards governing veterinary diagnostics. Additionally, maintaining quality assurance across diverse geographies and addressing biosecurity and sample transport challenges remain key priorities for laboratories aiming to sustain accuracy, reliability, and growth momentum.
The clinical pathology segment accounted for the largest share of the market, by application, in 2024.
Based on application, the veterinary reference laboratory market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. In 2024, clinical pathology accounted for the largest share of the market. This dominance is attributed to the segment’s critical role in delivering detailed diagnostic insights through hematology, cytology, and clinical chemistry testing. These analyses enable veterinarians to accurately diagnose systemic disorders, track therapeutic progress, and effectively manage complex disease conditions. The rising companion animal population and increasing frequency of veterinary consultations have fueled the demand for routine pathology services. Moreover, technological advancements in automated analyzers and digital pathology systems have significantly improved diagnostic precision, efficiency, and turnaround time, further driving market growth in this segment.
The veterinary clinics & hospitals segment is expected to dominate the market, by end user, during the forecast period.
Based on end user, the veterinary reference laboratory market is segmented into veterinary clinics and hospitals, research institutes and universities, point-of-care/in-house labs, and other end users. In 2024, veterinary clinics and hospitals accounted for the largest share of the global market. This dominance is primarily driven by the rising volume of diagnostic testing conducted through referral partnerships with centralized laboratories, as clinics increasingly outsource advanced and specialized tests such as molecular diagnostics, immunodiagnostics, and clinical chemistry to improve diagnostic accuracy and efficiency.
The growing companion animal population, higher pet healthcare expenditure, and expanding network of small and large veterinary practices have further contributed to the rising sample inflow from clinics and hospitals. These facilities rely on reference laboratories for confirmatory and complex testing that cannot be efficiently performed in-house, thereby enhancing treatment outcomes and operational workflows. Additionally, the integration of digital sample management systems and automated result reporting between clinics and reference labs is improving turnaround times and supporting evidence-based veterinary care.
In 2024, North America dominated the veterinary reference laboratory market.
The veterinary reference laboratory market is segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. In 2024, North America accounted for the largest share of the global market. This dominance can be attributed to several key factors, including the high prevalence of companion animal ownership, strong awareness of preventive veterinary care, and significant healthcare expenditure on pets across the region. The presence of leading industry players such as IDEXX Laboratories, Zoetis Services LLC, and Mars, Incorporated, coupled with a well-established network of veterinary hospitals and diagnostic centers, has further reinforced the region’s leadership. Within North America, the United States held the largest market share, supported by the country’s advanced veterinary infrastructure, growing demand for specialized and molecular diagnostic testing, and rapid adoption of automation and digital pathology solutions. Additionally, the U.S. market benefits from favorable pet insurance penetration, a robust ecosystem of veterinary service providers, and strong investment in R&D for companion and livestock diagnostic innovations.
Breakdown of supply-side primary interviews:
This report studies the veterinary reference laboratory market based on service, application, animal type, end user, and region. It also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the market's opportunities and challenges and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six main regions and respective countries.
Reasons to Buy the Report
The report can help established companies and new or smaller firms understand market trends, which will help them capture a larger market share. Firms that purchase the report can utilize one or more of the five strategies mentioned below.
This report provides insights into the following points:
At the same time, the increasing integration of diagnostic services with digital platforms and laboratory information management systems (LIMS) is streamlining workflows, enhancing sample traceability, and enabling remote access to test results. The rising focus on early disease detection and companion animal wellness programs further supports test adoption, while expanding veterinary corporatization and partnerships between clinics and reference labs are driving consistent sample inflows. However, the market faces challenges such as high operational and testing costs, a shortage of skilled laboratory professionals, and stringent regulatory standards governing veterinary diagnostics. Additionally, maintaining quality assurance across diverse geographies and addressing biosecurity and sample transport challenges remain key priorities for laboratories aiming to sustain accuracy, reliability, and growth momentum.
The clinical pathology segment accounted for the largest share of the market, by application, in 2024.
Based on application, the veterinary reference laboratory market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. In 2024, clinical pathology accounted for the largest share of the market. This dominance is attributed to the segment’s critical role in delivering detailed diagnostic insights through hematology, cytology, and clinical chemistry testing. These analyses enable veterinarians to accurately diagnose systemic disorders, track therapeutic progress, and effectively manage complex disease conditions. The rising companion animal population and increasing frequency of veterinary consultations have fueled the demand for routine pathology services. Moreover, technological advancements in automated analyzers and digital pathology systems have significantly improved diagnostic precision, efficiency, and turnaround time, further driving market growth in this segment.
The veterinary clinics & hospitals segment is expected to dominate the market, by end user, during the forecast period.
Based on end user, the veterinary reference laboratory market is segmented into veterinary clinics and hospitals, research institutes and universities, point-of-care/in-house labs, and other end users. In 2024, veterinary clinics and hospitals accounted for the largest share of the global market. This dominance is primarily driven by the rising volume of diagnostic testing conducted through referral partnerships with centralized laboratories, as clinics increasingly outsource advanced and specialized tests such as molecular diagnostics, immunodiagnostics, and clinical chemistry to improve diagnostic accuracy and efficiency.
The growing companion animal population, higher pet healthcare expenditure, and expanding network of small and large veterinary practices have further contributed to the rising sample inflow from clinics and hospitals. These facilities rely on reference laboratories for confirmatory and complex testing that cannot be efficiently performed in-house, thereby enhancing treatment outcomes and operational workflows. Additionally, the integration of digital sample management systems and automated result reporting between clinics and reference labs is improving turnaround times and supporting evidence-based veterinary care.
In 2024, North America dominated the veterinary reference laboratory market.
The veterinary reference laboratory market is segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. In 2024, North America accounted for the largest share of the global market. This dominance can be attributed to several key factors, including the high prevalence of companion animal ownership, strong awareness of preventive veterinary care, and significant healthcare expenditure on pets across the region. The presence of leading industry players such as IDEXX Laboratories, Zoetis Services LLC, and Mars, Incorporated, coupled with a well-established network of veterinary hospitals and diagnostic centers, has further reinforced the region’s leadership. Within North America, the United States held the largest market share, supported by the country’s advanced veterinary infrastructure, growing demand for specialized and molecular diagnostic testing, and rapid adoption of automation and digital pathology solutions. Additionally, the U.S. market benefits from favorable pet insurance penetration, a robust ecosystem of veterinary service providers, and strong investment in R&D for companion and livestock diagnostic innovations.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
- By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)
- By Company Type: Veterinary Clinics & Hospitals (70%), POC/In-house labs (15%), Research Institutions and Universities (10%), and Other End Users (5%)
- By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)
This report studies the veterinary reference laboratory market based on service, application, animal type, end user, and region. It also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the market's opportunities and challenges and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six main regions and respective countries.
Reasons to Buy the Report
The report can help established companies and new or smaller firms understand market trends, which will help them capture a larger market share. Firms that purchase the report can utilize one or more of the five strategies mentioned below.
This report provides insights into the following points:
- Analysis of key drivers, opportunities, restraints, and challenges influencing the growth of the veterinary reference laboratory market.
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and service launches in the veterinary reference laboratory market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary reference laboratory services across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary reference laboratory market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary reference laboratory market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 INCLUSIONS & EXCLUSIONS
1.3.4 YEARS CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key sources of secondary research
2.2.1.2 Key objectives of secondary research
2.2.1.3 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key primary sources
2.2.2.2 Key objectives of primary research
2.2.2.3 Key data from primary sources
2.2.2.4 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 REVENUE SHARE ANALYSIS
2.3.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.3.3 DEMAND-SIDE ANALYSIS
2.3.4 TOP-DOWN APPROACH
2.3.5 BOTTOM-UP APPROACH
2.4 DATA TRIANGULATION
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.6.1 MARKET ASSUMPTIONS
2.6.2 GROWTH RATE ASSUMPTIONS
2.7 RISK ANALYSIS
2.8 RESEARCH LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VETERINARY REFERENCE LABORATORY MARKET OVERVIEW
4.2 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY PRODUCT AND COUNTRY (2024)
4.3 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL MIX
4.4 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 VETERINARY REFERENCE LABORATORY MARKET: DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 DRIVERS
5.1.1.1 Growing routine wellness and oncology screening in companion animals
5.1.1.2 Rapid adoption of digital pathology and telepathology
5.1.1.3 Increasing prevalence/awareness of zoonotic and emerging diseases
5.1.1.4 Growth in companion animal population
5.1.1.5 Rising demand for animal-derived food products
5.1.1.6 Increasing demand for pet insurance and growing animal health expenditure
5.1.2 RESTRAINTS
5.1.2.1 Competition from in-clinic and point-of-care testing
5.1.2.2 High capital investment and fixed cost burden in veterinary reference laboratories
5.1.3 OPPORTUNITIES
5.1.3.1 Potential growth opportunities in emerging economies
5.1.3.2 Investment in advanced technologies in veterinary reference laboratories
5.1.4 CHALLENGES
5.1.4.1 Competitive pressure and margin pressure in veterinary reference laboratories
5.1.4.2 Data privacy, biosecurity, and sample ownership in veterinary reference laboratories
5.2 INDUSTRY TRENDS
5.2.1 DIGITAL PATHOLOGY, TELECYTOLOGY, AND AI FROM PILOT TO COMMERCIAL SERVICES
5.2.2 CONTINUED CONSOLIDATION AND VERTICAL INTEGRATION ACROSS ANIMAL-HEALTH ECOSYSTEM
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Real-time PCR/Quantitative PCR (qPCR) and digital PCR (dPCR)
5.3.1.2 Next-generation/Metagenomic sequencing (NGS/mNGS)
5.3.1.3 CRISPR-based diagnostics
5.3.2 ADJACENT TECHNOLOGIES
5.3.2.1 Integrated LIMS and one health surveillance platforms
5.3.2.2 AI-driven diagnostic tools
5.3.3 COMPLEMENTARY TECHNOLOGIES
5.3.3.1 Telepathology
5.3.3.2 Breath and saliva-based diagnostic tools
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 KEY STAKEHOLDERS & BUYING CRITERIA
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.5.2 KEY BUYING CRITERIA
5.6 REGULATORY ANALYSIS
5.6.1 REGULATORY LANDSCAPE
5.6.1.1 North America
5.6.1.1.1 US
5.6.1.2 Europe
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR VETERINARY REFERENCE LABORATORY
5.7.2 JURISDICTION & TOP APPLICANT ANALYSIS
5.7.3 MAJOR PATENTS
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022?2024
5.8.2 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022–2024
5.9 REIMBURSEMENT ANALYSIS
5.10 PET PARENT BEHAVIOUR
5.11 KEY CONFERENCES & EVENTS, 2025–2026
5.12 END-USER PERSPECTIVE & UNMET NEEDS
5.13 IMPACT OF AI/GEN AI ON VETERINARY REFERENCE LABORATORY MARKET
5.13.1 INTRODUCTION
5.13.2 MARKET POTENTIAL IN VETERINARY REFERENCE LABORATORY ECOSYSTEM
5.13.3 AI-USE CASES
5.13.4 KEY COMPANIES IMPLEMENTING AI
5.14 ECOSYSTEM MAP
5.15 ROLE IN ECOSYSTEM
5.16 VALUE CHAIN ANALYSIS
5.17 INVESTMENT & FUNDING SCENARIO
5.18 CASE STUDY ANALYSIS
5.18.1 DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES
5.18.2 IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING
5.18.3 VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.20 IMPACT OF 2025 US TARIFF ON VETERINARY REFERENCE LABORATORY MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON COUNTRY/REGION
5.20.4.1 North America
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.4.4 Latin America
5.20.5 IMPACT ON END-USE INDUSTRIES
5.20.5.1 Veterinary hospitals & clinics
5.20.5.2 Point-of-care (POC) and in-house testing setups
5.20.5.3 Veterinary research institutes & universities
5.20.5.4 Other end users
6 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE
6.1 INTRODUCTION
6.2 CLINICAL CHEMISTRY
6.2.1 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE
6.2.1.1 Companion animals
6.2.1.1.1 Rising pet ownership and preventive health trends to drive segment growth
6.2.1.2 Livestock animals
6.2.1.2.1 Rising focus on herd health, food safety, and export compliance to strengthen segment growth
6.3 IMMUNODIAGNOSTICS
6.3.1 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE
6.3.1.1 ELISA
6.3.1.1.1 ELISA tests to dominate immunodiagnostics segment owing to widespread use in infectious disease detection
6.3.2 LATERAL FLOW ASSAYS
6.3.2.1 Technological advancements and cost-effectiveness to aid market growth
6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
6.3.3.1 Rising prevalence of atopic disorders and adoption of precision allergy testing to augment market growth
6.3.4 OTHER IMMUNODIAGNOSTIC SERVICES
6.3.5 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE
6.3.5.1 Companion animals
6.3.5.1.1 High pet care spending and preventive diagnostics to propel market growth
6.3.5.2 Livestock animals
6.3.5.2.1 Regulatory compliance, food safety, and disease surveillance to sustain steady demand
6.4 MOLECULAR DIAGNOSTICS
6.4.1 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE
6.4.2 PCR TESTS
6.4.2.1 High sensitivity and diagnostic accuracy to drive dominance of PCR tests
6.4.3 MICROARRAYS
6.4.3.1 Advancements in genetic profiling and pharmacogenomics to expand microarray applications
6.4.4 NUCLEIC ACID SEQUENCING
6.4.4.1 Rising adoption of next-generation sequencing and precision genomics to fuel market growth
6.4.5 OTHER MOLECULAR DIAGNOSTIC SERVICES
6.4.6 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE
6.4.6.1 Companion animals
6.4.6.1.1 High pet-owner spending, precision diagnostics, and rapid turnaround to drive dominance
6.4.6.2 Livestock animals
6.4.6.2.1 Regulatory mandates, disease surveillance, and one health initiatives to strengthen market presence
6.5 HEMATOLOGY
6.5.1 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE
6.5.1.1 Companion animals
6.5.1.1.1 High diagnostic frequency and technological advancements TO sustain segment growth
6.5.1.2 Livestock animals
6.5.1.2.1 Rising focus on herd health, biosecurity, and productivity optimization to drive steady market growth
6.6 URINALYSIS
6.6.1 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE
6.6.1.1 Companion animals
6.6.1.1.1 Rising incidences of renal diseases in companion animals to drive market
6.6.1.2 Livestock animals
6.6.1.2.1 Growing emphasis on metabolic profiling and precision herd management to strengthen livestock urinalysis segment
6.7 HISTOPATHOLOGY & CYTOLOGY
6.7.1 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE
6.7.1.1 Companion animals
6.7.1.1.1 Clinical reliance on laboratory-based tissue and cellular diagnostics for definitive case management to drive market
6.7.1.2 Livestock animals
6.7.1.2.1 Biosecurity investments and disease surveillance programs to drive steady demand
6.8 MICROBIOLOGY
6.8.1 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE
6.8.1.1 Companion animals
6.8.1.1.1 Rising AMR awareness and shift toward rapid and automated testing to spur market growth
6.8.1.2 Livestock animals
6.8.1.2.1 Antimicrobial resistance monitoring and food safety compliance to sustain demand
6.9 OTHER SERVICES
6.9.1 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY ANIMAL TYPE
6.9.1.1 Companion animals
6.9.1.2 Livestock animals
7 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CLINICAL PATHOLOGY
7.2.1 INCREASING AWARENESS OF ANIMAL HEALTH TO DRIVE MARKET
7.3 BACTERIOLOGY
7.3.1 GROWTH IN VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET
7.4 VIROLOGY
7.4.1 EMERGING INFECTIOUS DISEASES IN ANIMALS TO PROPEL MARKET GROWTH
7.5 PARASITOLOGY
7.5.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO AUGMENT MARKET GROWTH
7.6 PRODUCTIVITY TESTING
7.6.1 EXPANSION OF LIVESTOCK INDUSTRIES TO SUPPORT MARKET GROWTH
7.7 PREGNANCY TESTING
7.7.1 ADVANCED BREEDING TECHNIQUES AND RESPONSIBLE PET OWNERSHIP TO DRIVE MARKET GROWTH
7.8 TOXICOLOGY TESTING
7.8.1 GLOBALIZATION OF FOOD SUPPLY CHAINS TO PROPEL MARKET GROWTH
7.9 OTHER APPLICATIONS
8 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
8.2 COMPANION ANIMALS
8.2.1 DOGS
8.2.1.1 High insurance coverage and availability of reimbursements to drive market
8.2.2 CATS
8.2.2.1 Increasing pet cat population to support market uptake
8.2.3 HORSES
8.2.3.1 Growing awareness regarding equine health to fuel market growth
8.2.4 OTHER COMPANION ANIMALS
8.3 LIVESTOCK ANIMALS
8.3.1 CATTLE
8.3.1.1 Growing consumption of dairy products to drive market growth
8.3.2 SWINE
8.3.2.1 Increasing incidence of infectious diseases to fuel market growth
8.3.3 POULTRY
8.3.3.1 Increasing demand for poultry meat to spur market growth
8.3.4 SHEEP & GOATS
8.3.4.1 International trade and strict health regulations to drive market
8.3.5 OTHER LIVESTOCK ANIMALS
9 VETERINARY REFERENCE LABORATORY MARKET, BY END USER
9.1 INTRODUCTION
9.2 VETERINARY HOSPITALS & CLINICS
9.2.1 RISING PET OWNERSHIP AND GROWING DIAGNOSTIC AWARENESS TO DRIVE DEMAND FOR VETERINARY REFERENCE LABS
9.3 POINT-OF-CARE/IN-HOUSE TESTING
9.3.1 INCREASING COLLABORATIONS BETWEEN IN-HOUSE DIAGNOSTIC SETUPS AND REFERENCE LABORATORIES TO AID MARKET GROWTH
9.4 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
9.4.1 INCREASING ACADEMIC COLLABORATIONS AND FUNDING TO DRIVE UTILIZATION OF REFERENCE LABORATORY SERVICES
9.5 OTHER END USERS
10 VETERINARY REFERENCE LABORATORY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate Norths American veterinary reference laboratory market during forecast period
10.2.3 CANADA
10.2.3.1 Growing pet adoption, rising animal healthcare expenditure, and increasing number of veterinary practices to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Increasing pet healthcare expenditure and rising demand for animal-derived food products to aid market growth
10.3.3 UK
10.3.3.1 Increased pet ownership and availability of animal health insurance policies to augment market growth
10.3.4 FRANCE
10.3.4.1 Growth of livestock industry and high companion animal population to support market growth
10.3.5 ITALY
10.3.5.1 Rising awareness about pet healthcare to drive market
10.3.6 SPAIN
10.3.6.1 Growing demand for pig and poultry products to drive market
10.3.7 NETHERLANDS
10.3.7.1 Increasing animal healthcare expenditure to drive market growth
10.3.8 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 CHINA
10.4.2.1 Large pool of food-producing animals to drive market
10.4.3 JAPAN
10.4.3.1 Awareness about zoonotic diseases and increased pet expenditure to propel market growth
10.4.4 INDIA
10.4.4.1 Growing demand for livestock products and increasing awareness about animal health to support market growth
10.4.5 AUSTRALIA
10.4.5.1 Increasing investments in pet services and products to aid market growth
10.4.6 SOUTH KOREA
10.4.6.1 Increasing pet population in urban households to drive market
10.4.7 THAILAND
10.4.7.1 Rapidly expanding companion animal population to create higher demand for advanced diagnostic testing
10.4.8 NEW ZEALAND
10.4.8.1 Increased demand for preventive care and high aging pet population to drive market growth
10.4.9 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Increasing use of reproductive technologies in livestock industry to propel market growth
10.5.3 MEXICO
10.5.3.1 Increasing adoption of advanced diagnostic technologies to propel market growth
10.5.4 ARGENTINA
10.5.4.1 Focus on advanced healthcare and regular disease monitoring among companion animals to drive market
10.5.5 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Kingdom of Saudi Arabia
10.6.2.1.1 Technology advancements in veterinary diagnostics to boost market growth
10.6.2.2 UAE
10.6.2.2.1 Government support and favorable initiatives to fuel market growth
10.6.2.3 Rest of GCC Countries
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET
11.3 REVENUE ANALYSIS, 2020?2024
11.4 MARKET SHARE ANALYSIS, 2024
11.4.1 RANKING OF KEY MARKET PLAYERS
11.4.2 GLOBAL MARKET SHARE ANALYSIS
11.4.3 US MARKET SHARE ANALYSIS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Service footprint
11.5.5.4 Animal type footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SME PLAYERS, 2024
11.6.5.1 Detailed list of key startups/SME players
11.6.5.2 Competitive benchmarking of key emerging players/startups
11.7 BRAND/PRODUCT COMPARISON
11.8 R&D EXPENDITURE OF KEY PLAYERS
11.9 COMPANY VALUATION & FINANCIAL METRICS
11.9.1 FINANCIAL METRICS
11.9.2 COMPANY VALUATION
11.10 COMPETITIVE SCENARIO
11.10.1 SERVICE LAUNCHES & ENHANCEMENTS
11.10.2 DEALS
11.10.3 EXPANSIONS
11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 IDEXX LABORATORIES, INC.
12.1.1.1 Business overview
12.1.1.2 Services offered
12.1.1.3 Recent developments
12.1.1.3.1 Service launches and enhancements
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 MARS, INCORPORATED
12.1.2.1 Business overview
12.1.2.2 Services offered
12.1.2.3 Recent developments
12.1.2.3.1 Service launches
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 ZOETIS SERVICES LLC
12.1.3.1 Business overview
12.1.3.2 Services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.3.2 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 GD (ROYAL GD ANIMAL HEALTH)
12.1.4.1 Business overview
12.1.4.2 Services offered
12.1.4.3 Recent developments
12.1.4.3.1 Service launches
12.1.4.3.2 Deals
12.1.4.3.3 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 LABOKLIN GMBH & CO. KG
12.1.5.1 Business overview
12.1.5.2 Services offered
12.1.5.3 Recent developments
12.1.5.3.1 Service launches
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 CVS (UK) LIMITED
12.1.6.1 Business overview
12.1.6.2 Services offered
12.1.6.3 Recent developments
12.1.6.3.1 Service launches
12.1.7 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS
12.1.7.1 Business overview
12.1.7.2 Services offered
12.1.8 ANIMAL AND PLANT HEALTH AGENCY
12.1.8.1 Business overview
12.1.8.2 Services offered
12.1.8.3 Recent developments
12.1.8.3.1 Other developments
12.1.9 ICAR–NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS)
12.1.9.1 Business overview
12.1.9.2 Services offered
12.1.10 NATIONAL VETERINARY SERVICES
12.1.10.1 Business overview
12.1.10.2 Services offered
12.1.10.3 Recent developments
12.1.10.3.1 Expansions
12.1.10.3.2 Other developments
12.1.11 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL)
12.1.11.1 Business overview
12.1.11.2 Services offered
12.1.11.3 Recent developments
12.1.11.3.1 Service launches and enhancements
12.1.12 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY
12.1.12.1 Business overview
12.1.12.2 Services offered
12.1.12.3 Recent developments
12.1.12.3.1 Service launches
12.1.12.3.2 Expansions
12.1.13 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY)
12.1.13.1 Business overview
12.1.13.2 Services offered
12.1.14 BIOBEST LABORATORIES LTD.
12.1.14.1 Business overview
12.1.14.2 Services offered
12.1.14.3 Recent developments
12.1.14.3.1 Expansions
12.1.15 PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE
12.1.15.1 Business overview
12.1.15.2 Services offered
12.2 OTHER PLAYERS
12.2.1 ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON
12.2.2 UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY
12.2.3 VAXXINOVA
12.2.4 MIRA VISTA LABS
12.2.5 ELLIE DIAGNOSTICS
12.2.6 PROTATEK INTERNATIONAL, INC.
12.2.7 THE PIRBRIGHT INSTITUTE
12.2.8 CVR LABORATORY (CVRL)
12.2.9 VETERINARY PATHOLOGY GROUP
12.2.10 FRIEDRICH-LOEFFLER-INSTITUT (FLI)
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.3.1 SERVICE ANALYSIS
13.3.2 COMPANY INFORMATION
13.3.3 GEOGRAPHIC ANALYSIS
13.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
13.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT
13.3.6 BY SERVICE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
13.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 INCLUSIONS & EXCLUSIONS
1.3.4 YEARS CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key sources of secondary research
2.2.1.2 Key objectives of secondary research
2.2.1.3 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key primary sources
2.2.2.2 Key objectives of primary research
2.2.2.3 Key data from primary sources
2.2.2.4 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 REVENUE SHARE ANALYSIS
2.3.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.3.3 DEMAND-SIDE ANALYSIS
2.3.4 TOP-DOWN APPROACH
2.3.5 BOTTOM-UP APPROACH
2.4 DATA TRIANGULATION
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.6.1 MARKET ASSUMPTIONS
2.6.2 GROWTH RATE ASSUMPTIONS
2.7 RISK ANALYSIS
2.8 RESEARCH LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VETERINARY REFERENCE LABORATORY MARKET OVERVIEW
4.2 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY PRODUCT AND COUNTRY (2024)
4.3 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL MIX
4.4 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 VETERINARY REFERENCE LABORATORY MARKET: DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 DRIVERS
5.1.1.1 Growing routine wellness and oncology screening in companion animals
5.1.1.2 Rapid adoption of digital pathology and telepathology
5.1.1.3 Increasing prevalence/awareness of zoonotic and emerging diseases
5.1.1.4 Growth in companion animal population
5.1.1.5 Rising demand for animal-derived food products
5.1.1.6 Increasing demand for pet insurance and growing animal health expenditure
5.1.2 RESTRAINTS
5.1.2.1 Competition from in-clinic and point-of-care testing
5.1.2.2 High capital investment and fixed cost burden in veterinary reference laboratories
5.1.3 OPPORTUNITIES
5.1.3.1 Potential growth opportunities in emerging economies
5.1.3.2 Investment in advanced technologies in veterinary reference laboratories
5.1.4 CHALLENGES
5.1.4.1 Competitive pressure and margin pressure in veterinary reference laboratories
5.1.4.2 Data privacy, biosecurity, and sample ownership in veterinary reference laboratories
5.2 INDUSTRY TRENDS
5.2.1 DIGITAL PATHOLOGY, TELECYTOLOGY, AND AI FROM PILOT TO COMMERCIAL SERVICES
5.2.2 CONTINUED CONSOLIDATION AND VERTICAL INTEGRATION ACROSS ANIMAL-HEALTH ECOSYSTEM
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Real-time PCR/Quantitative PCR (qPCR) and digital PCR (dPCR)
5.3.1.2 Next-generation/Metagenomic sequencing (NGS/mNGS)
5.3.1.3 CRISPR-based diagnostics
5.3.2 ADJACENT TECHNOLOGIES
5.3.2.1 Integrated LIMS and one health surveillance platforms
5.3.2.2 AI-driven diagnostic tools
5.3.3 COMPLEMENTARY TECHNOLOGIES
5.3.3.1 Telepathology
5.3.3.2 Breath and saliva-based diagnostic tools
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 KEY STAKEHOLDERS & BUYING CRITERIA
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.5.2 KEY BUYING CRITERIA
5.6 REGULATORY ANALYSIS
5.6.1 REGULATORY LANDSCAPE
5.6.1.1 North America
5.6.1.1.1 US
5.6.1.2 Europe
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR VETERINARY REFERENCE LABORATORY
5.7.2 JURISDICTION & TOP APPLICANT ANALYSIS
5.7.3 MAJOR PATENTS
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022?2024
5.8.2 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022–2024
5.9 REIMBURSEMENT ANALYSIS
5.10 PET PARENT BEHAVIOUR
5.11 KEY CONFERENCES & EVENTS, 2025–2026
5.12 END-USER PERSPECTIVE & UNMET NEEDS
5.13 IMPACT OF AI/GEN AI ON VETERINARY REFERENCE LABORATORY MARKET
5.13.1 INTRODUCTION
5.13.2 MARKET POTENTIAL IN VETERINARY REFERENCE LABORATORY ECOSYSTEM
5.13.3 AI-USE CASES
5.13.4 KEY COMPANIES IMPLEMENTING AI
5.14 ECOSYSTEM MAP
5.15 ROLE IN ECOSYSTEM
5.16 VALUE CHAIN ANALYSIS
5.17 INVESTMENT & FUNDING SCENARIO
5.18 CASE STUDY ANALYSIS
5.18.1 DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES
5.18.2 IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING
5.18.3 VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.20 IMPACT OF 2025 US TARIFF ON VETERINARY REFERENCE LABORATORY MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON COUNTRY/REGION
5.20.4.1 North America
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.4.4 Latin America
5.20.5 IMPACT ON END-USE INDUSTRIES
5.20.5.1 Veterinary hospitals & clinics
5.20.5.2 Point-of-care (POC) and in-house testing setups
5.20.5.3 Veterinary research institutes & universities
5.20.5.4 Other end users
6 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE
6.1 INTRODUCTION
6.2 CLINICAL CHEMISTRY
6.2.1 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE
6.2.1.1 Companion animals
6.2.1.1.1 Rising pet ownership and preventive health trends to drive segment growth
6.2.1.2 Livestock animals
6.2.1.2.1 Rising focus on herd health, food safety, and export compliance to strengthen segment growth
6.3 IMMUNODIAGNOSTICS
6.3.1 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE
6.3.1.1 ELISA
6.3.1.1.1 ELISA tests to dominate immunodiagnostics segment owing to widespread use in infectious disease detection
6.3.2 LATERAL FLOW ASSAYS
6.3.2.1 Technological advancements and cost-effectiveness to aid market growth
6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
6.3.3.1 Rising prevalence of atopic disorders and adoption of precision allergy testing to augment market growth
6.3.4 OTHER IMMUNODIAGNOSTIC SERVICES
6.3.5 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE
6.3.5.1 Companion animals
6.3.5.1.1 High pet care spending and preventive diagnostics to propel market growth
6.3.5.2 Livestock animals
6.3.5.2.1 Regulatory compliance, food safety, and disease surveillance to sustain steady demand
6.4 MOLECULAR DIAGNOSTICS
6.4.1 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE
6.4.2 PCR TESTS
6.4.2.1 High sensitivity and diagnostic accuracy to drive dominance of PCR tests
6.4.3 MICROARRAYS
6.4.3.1 Advancements in genetic profiling and pharmacogenomics to expand microarray applications
6.4.4 NUCLEIC ACID SEQUENCING
6.4.4.1 Rising adoption of next-generation sequencing and precision genomics to fuel market growth
6.4.5 OTHER MOLECULAR DIAGNOSTIC SERVICES
6.4.6 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE
6.4.6.1 Companion animals
6.4.6.1.1 High pet-owner spending, precision diagnostics, and rapid turnaround to drive dominance
6.4.6.2 Livestock animals
6.4.6.2.1 Regulatory mandates, disease surveillance, and one health initiatives to strengthen market presence
6.5 HEMATOLOGY
6.5.1 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE
6.5.1.1 Companion animals
6.5.1.1.1 High diagnostic frequency and technological advancements TO sustain segment growth
6.5.1.2 Livestock animals
6.5.1.2.1 Rising focus on herd health, biosecurity, and productivity optimization to drive steady market growth
6.6 URINALYSIS
6.6.1 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE
6.6.1.1 Companion animals
6.6.1.1.1 Rising incidences of renal diseases in companion animals to drive market
6.6.1.2 Livestock animals
6.6.1.2.1 Growing emphasis on metabolic profiling and precision herd management to strengthen livestock urinalysis segment
6.7 HISTOPATHOLOGY & CYTOLOGY
6.7.1 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE
6.7.1.1 Companion animals
6.7.1.1.1 Clinical reliance on laboratory-based tissue and cellular diagnostics for definitive case management to drive market
6.7.1.2 Livestock animals
6.7.1.2.1 Biosecurity investments and disease surveillance programs to drive steady demand
6.8 MICROBIOLOGY
6.8.1 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE
6.8.1.1 Companion animals
6.8.1.1.1 Rising AMR awareness and shift toward rapid and automated testing to spur market growth
6.8.1.2 Livestock animals
6.8.1.2.1 Antimicrobial resistance monitoring and food safety compliance to sustain demand
6.9 OTHER SERVICES
6.9.1 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY ANIMAL TYPE
6.9.1.1 Companion animals
6.9.1.2 Livestock animals
7 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CLINICAL PATHOLOGY
7.2.1 INCREASING AWARENESS OF ANIMAL HEALTH TO DRIVE MARKET
7.3 BACTERIOLOGY
7.3.1 GROWTH IN VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET
7.4 VIROLOGY
7.4.1 EMERGING INFECTIOUS DISEASES IN ANIMALS TO PROPEL MARKET GROWTH
7.5 PARASITOLOGY
7.5.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO AUGMENT MARKET GROWTH
7.6 PRODUCTIVITY TESTING
7.6.1 EXPANSION OF LIVESTOCK INDUSTRIES TO SUPPORT MARKET GROWTH
7.7 PREGNANCY TESTING
7.7.1 ADVANCED BREEDING TECHNIQUES AND RESPONSIBLE PET OWNERSHIP TO DRIVE MARKET GROWTH
7.8 TOXICOLOGY TESTING
7.8.1 GLOBALIZATION OF FOOD SUPPLY CHAINS TO PROPEL MARKET GROWTH
7.9 OTHER APPLICATIONS
8 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
8.2 COMPANION ANIMALS
8.2.1 DOGS
8.2.1.1 High insurance coverage and availability of reimbursements to drive market
8.2.2 CATS
8.2.2.1 Increasing pet cat population to support market uptake
8.2.3 HORSES
8.2.3.1 Growing awareness regarding equine health to fuel market growth
8.2.4 OTHER COMPANION ANIMALS
8.3 LIVESTOCK ANIMALS
8.3.1 CATTLE
8.3.1.1 Growing consumption of dairy products to drive market growth
8.3.2 SWINE
8.3.2.1 Increasing incidence of infectious diseases to fuel market growth
8.3.3 POULTRY
8.3.3.1 Increasing demand for poultry meat to spur market growth
8.3.4 SHEEP & GOATS
8.3.4.1 International trade and strict health regulations to drive market
8.3.5 OTHER LIVESTOCK ANIMALS
9 VETERINARY REFERENCE LABORATORY MARKET, BY END USER
9.1 INTRODUCTION
9.2 VETERINARY HOSPITALS & CLINICS
9.2.1 RISING PET OWNERSHIP AND GROWING DIAGNOSTIC AWARENESS TO DRIVE DEMAND FOR VETERINARY REFERENCE LABS
9.3 POINT-OF-CARE/IN-HOUSE TESTING
9.3.1 INCREASING COLLABORATIONS BETWEEN IN-HOUSE DIAGNOSTIC SETUPS AND REFERENCE LABORATORIES TO AID MARKET GROWTH
9.4 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
9.4.1 INCREASING ACADEMIC COLLABORATIONS AND FUNDING TO DRIVE UTILIZATION OF REFERENCE LABORATORY SERVICES
9.5 OTHER END USERS
10 VETERINARY REFERENCE LABORATORY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate Norths American veterinary reference laboratory market during forecast period
10.2.3 CANADA
10.2.3.1 Growing pet adoption, rising animal healthcare expenditure, and increasing number of veterinary practices to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Increasing pet healthcare expenditure and rising demand for animal-derived food products to aid market growth
10.3.3 UK
10.3.3.1 Increased pet ownership and availability of animal health insurance policies to augment market growth
10.3.4 FRANCE
10.3.4.1 Growth of livestock industry and high companion animal population to support market growth
10.3.5 ITALY
10.3.5.1 Rising awareness about pet healthcare to drive market
10.3.6 SPAIN
10.3.6.1 Growing demand for pig and poultry products to drive market
10.3.7 NETHERLANDS
10.3.7.1 Increasing animal healthcare expenditure to drive market growth
10.3.8 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 CHINA
10.4.2.1 Large pool of food-producing animals to drive market
10.4.3 JAPAN
10.4.3.1 Awareness about zoonotic diseases and increased pet expenditure to propel market growth
10.4.4 INDIA
10.4.4.1 Growing demand for livestock products and increasing awareness about animal health to support market growth
10.4.5 AUSTRALIA
10.4.5.1 Increasing investments in pet services and products to aid market growth
10.4.6 SOUTH KOREA
10.4.6.1 Increasing pet population in urban households to drive market
10.4.7 THAILAND
10.4.7.1 Rapidly expanding companion animal population to create higher demand for advanced diagnostic testing
10.4.8 NEW ZEALAND
10.4.8.1 Increased demand for preventive care and high aging pet population to drive market growth
10.4.9 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Increasing use of reproductive technologies in livestock industry to propel market growth
10.5.3 MEXICO
10.5.3.1 Increasing adoption of advanced diagnostic technologies to propel market growth
10.5.4 ARGENTINA
10.5.4.1 Focus on advanced healthcare and regular disease monitoring among companion animals to drive market
10.5.5 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Kingdom of Saudi Arabia
10.6.2.1.1 Technology advancements in veterinary diagnostics to boost market growth
10.6.2.2 UAE
10.6.2.2.1 Government support and favorable initiatives to fuel market growth
10.6.2.3 Rest of GCC Countries
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET
11.3 REVENUE ANALYSIS, 2020?2024
11.4 MARKET SHARE ANALYSIS, 2024
11.4.1 RANKING OF KEY MARKET PLAYERS
11.4.2 GLOBAL MARKET SHARE ANALYSIS
11.4.3 US MARKET SHARE ANALYSIS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Service footprint
11.5.5.4 Animal type footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SME PLAYERS, 2024
11.6.5.1 Detailed list of key startups/SME players
11.6.5.2 Competitive benchmarking of key emerging players/startups
11.7 BRAND/PRODUCT COMPARISON
11.8 R&D EXPENDITURE OF KEY PLAYERS
11.9 COMPANY VALUATION & FINANCIAL METRICS
11.9.1 FINANCIAL METRICS
11.9.2 COMPANY VALUATION
11.10 COMPETITIVE SCENARIO
11.10.1 SERVICE LAUNCHES & ENHANCEMENTS
11.10.2 DEALS
11.10.3 EXPANSIONS
11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 IDEXX LABORATORIES, INC.
12.1.1.1 Business overview
12.1.1.2 Services offered
12.1.1.3 Recent developments
12.1.1.3.1 Service launches and enhancements
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 MARS, INCORPORATED
12.1.2.1 Business overview
12.1.2.2 Services offered
12.1.2.3 Recent developments
12.1.2.3.1 Service launches
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 ZOETIS SERVICES LLC
12.1.3.1 Business overview
12.1.3.2 Services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.3.2 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 GD (ROYAL GD ANIMAL HEALTH)
12.1.4.1 Business overview
12.1.4.2 Services offered
12.1.4.3 Recent developments
12.1.4.3.1 Service launches
12.1.4.3.2 Deals
12.1.4.3.3 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 LABOKLIN GMBH & CO. KG
12.1.5.1 Business overview
12.1.5.2 Services offered
12.1.5.3 Recent developments
12.1.5.3.1 Service launches
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 CVS (UK) LIMITED
12.1.6.1 Business overview
12.1.6.2 Services offered
12.1.6.3 Recent developments
12.1.6.3.1 Service launches
12.1.7 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS
12.1.7.1 Business overview
12.1.7.2 Services offered
12.1.8 ANIMAL AND PLANT HEALTH AGENCY
12.1.8.1 Business overview
12.1.8.2 Services offered
12.1.8.3 Recent developments
12.1.8.3.1 Other developments
12.1.9 ICAR–NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS)
12.1.9.1 Business overview
12.1.9.2 Services offered
12.1.10 NATIONAL VETERINARY SERVICES
12.1.10.1 Business overview
12.1.10.2 Services offered
12.1.10.3 Recent developments
12.1.10.3.1 Expansions
12.1.10.3.2 Other developments
12.1.11 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL)
12.1.11.1 Business overview
12.1.11.2 Services offered
12.1.11.3 Recent developments
12.1.11.3.1 Service launches and enhancements
12.1.12 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY
12.1.12.1 Business overview
12.1.12.2 Services offered
12.1.12.3 Recent developments
12.1.12.3.1 Service launches
12.1.12.3.2 Expansions
12.1.13 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY)
12.1.13.1 Business overview
12.1.13.2 Services offered
12.1.14 BIOBEST LABORATORIES LTD.
12.1.14.1 Business overview
12.1.14.2 Services offered
12.1.14.3 Recent developments
12.1.14.3.1 Expansions
12.1.15 PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE
12.1.15.1 Business overview
12.1.15.2 Services offered
12.2 OTHER PLAYERS
12.2.1 ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON
12.2.2 UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY
12.2.3 VAXXINOVA
12.2.4 MIRA VISTA LABS
12.2.5 ELLIE DIAGNOSTICS
12.2.6 PROTATEK INTERNATIONAL, INC.
12.2.7 THE PIRBRIGHT INSTITUTE
12.2.8 CVR LABORATORY (CVRL)
12.2.9 VETERINARY PATHOLOGY GROUP
12.2.10 FRIEDRICH-LOEFFLER-INSTITUT (FLI)
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.3.1 SERVICE ANALYSIS
13.3.2 COMPANY INFORMATION
13.3.3 GEOGRAPHIC ANALYSIS
13.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
13.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT
13.3.6 BY SERVICE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
13.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 VETERINARY REFERENCE LABORATORY MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
TABLE 3 VETERINARY REFERENCE LABORATORY MARKET: MARKET ASSUMPTIONS
TABLE 4 VETERINARY REFERENCE LABORATORY MARKET: RISK ANALYSIS
TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES, 2009–2023
TABLE 6 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024,BY ANIMAL TYPE (MILLIONS)
TABLE 7 US: AVERAGE PREMIUMS PAID, 2020 VS. 2023
TABLE 8 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2023 (USD MILLION)
TABLE 9 VETERINARY REFERENCE LABORATORY MARKET: PORTER’S FIVE FORCES
TABLE 10 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORY PRODUCTS (%)
TABLE 11 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 MAJOR PATENTS IN VETERINARY REFERENCE LABORATORY MARKET
TABLE 16 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022–2024 (USD)
TABLE 17 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY SERVICES, BY REGION, 2022–2024 (USD)
TABLE 18 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022–2024 (USD)
TABLE 19 AVERAGE SELLING PRICE TREND OF MOLECULAR DIAGNOSTIC SERVICES,BY REGION, 2022–2024 (USD)
TABLE 20 AVERAGE SELLING PRICE TREND OF HAEMATOLOGY SERVICES, BY REGION, 2022–2024 (USD)
TABLE 21 AVERAGE SELLING PRICE TREND OF HISTOPATHOLOGY &CYTOLOGY SERVICES,BY REGION, 2022–2024 (USD)
TABLE 22 AVERAGE SELLING PRICE TREND OF URINALYSIS SERVICES, BY REGION,2022–2024 (USD)
TABLE 23 KEY CONFERENCES & EVENTS IN VETERINARY REFERENCE LABORATORY MARKET, JANUARY 2025–DECEMBER 2026
TABLE 24 KEY COMPANIES IMPLEMENTING AI IN VETERINARY REFERENCE LABORATORY MARKET
TABLE 25 VETERINARY REFERENCE LABORATORY PROVIDERS: ROLE IN ECOSYSTEM
TABLE 26 CASE STUDY 1: DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES
TABLE 27 CASE STUDY 2: IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING
TABLE 28 CASE STUDY 3: VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW
TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 30 KEY PRODUCT-RELATED TARIFF EFFECTIVE VETERINARY REFERENCE LABORATORY
TABLE 31 IMPACT OF US TARIFF ON CANADA
TABLE 32 IMPACT OF US TARIFF ON GERMANY AND UK
TABLE 33 IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA
TABLE 34 IMPACT OF US TARIFF ON MEXICO
TABLE 35 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 36 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY SERVICES
TABLE 37 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 39 CLINICAL CHEMISTRY MARKET FOR COMPANION ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 40 CLINICAL CHEMISTRY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
TABLE 42 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,BY SERVICE, 2023–2030 (USD MILLION)
TABLE 44 IMMUNODIAGNOSTICS MARKET FOR ELISA, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 45 IMMUNODIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46 IMMUNODIAGNOSTICS MARKET FOR ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47 OTHER IMMUNODIAGNOSTICS SERVICES MARKET, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 48 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,BY ANIMAL TYPE , 2023–2030 (USD MILLION)
TABLE 49 IMMUNODIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 50 IMMUNODIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 51 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC SERVICES
TABLE 52 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 54 MOLECULAR DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 55 MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 56 MOLECULAR DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57 OTHER MOLECULAR DIAGNOSTIC SERVICES MARKET, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 58 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 59 MOLECULAR DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60 MOLECULAR DIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61 KEY PLAYERS PROVIDING HAEMATOLOGY SERVICES
TABLE 62 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 64 HAEMATOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 65 HAEMATOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 66 KEY PLAYERS PROVIDING URINALYSIS TECHNOLOGIES
TABLE 67 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 69 URINALYSIS MARKET FOR COMPANION ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 70 URINALYSIS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 71 KEY PLAYERS PROVIDING HISTOPATHOLOGY & CYTOLOGY SERVICES
TABLE 72 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 74 HISTOPATHOLOGY & CYTOLOGY MARKET FOR COMPANION ANIMALS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 75 HISTOPATHOLOGY & CYTOLOGY MARKET FOR LIVESTOCK ANIMALS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76 KEY PLAYERS PROVIDING MICROBIOLOGY SERVICES
TABLE 77 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 79 MICROBIOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 80 MICROBIOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 81 KEY PLAYERS PROVIDING OTHER VETERINARY REFERENCE LABORATORY SERVICES
TABLE 82 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 84 OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85 OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,2023–2030 (USD MILLION)
TABLE 87 KEY PLAYERS PROVIDING CLINICAL PATHOLOGY SERVICES
TABLE 88 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL PATHOLOGY,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89 KEY PLAYERS PROVIDING BACTERIOLOGY SERVICES
TABLE 90 VETERINARY REFERENCE LABORATORY MARKET FOR BACTERIOLOGY,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91 KEY PLAYERS PROVIDING VIROLOGY SERVICES
TABLE 92 VETERINARY REFERENCE LABORATORY MARKET FOR VIROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93 KEY PLAYERS PROVIDING PARASITOLOGY SERVICES
TABLE 94 VETERINARY REFERENCE LABORATORY MARKET FOR PARASITOLOGY,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95 KEY PLAYERS PROVIDING PRODUCTIVITY TESTING SERVICES
TABLE 96 VETERINARY REFERENCE LABORATORY MARKET FOR PRODUCTIVITY TESTING,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97 KEY PLAYERS PROVIDING PREGNANCY TESTING SERVICES
TABLE 98 VETERINARY REFERENCE LABORATORY MARKET FOR PREGNANCY TESTING,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99 KEY PLAYERS PROVIDING TOXICOLOGY TESTING SERVICES
TABLE 100 VETERINARY REFERENCE LABORATORY MARKET FOR TOXICOLOGY TESTING,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 101 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER APPLICATIONS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,2023–2030 (USD MILLION)
TABLE 103 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR COMPANION ANIMALS
TABLE 104 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS,BY TYPE, 2023–2030 (USD MILLION)
TABLE 105 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR DOGS
TABLE 107 VETERINARY REFERENCE LABORATORY MARKET FOR DOGS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 108 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR CATS
TABLE 109 VETERINARY REFERENCE LABORATORY MARKET FOR CATS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 110 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR HORSES
TABLE 111 VETERINARY REFERENCE LABORATORY MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR LIVESTOCK ANIMALS
TABLE 114 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,BY TYPE, 2023–2030 (USD MILLION)
TABLE 115 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 116 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR CATTLE
TABLE 117 VETERINARY REFERENCE LABORATORY MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 118 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR SWINE
TABLE 119 VETERINARY REFERENCE LABORATORY MARKET FOR SWINE, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 120 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR POULTRY
TABLE 121 VETERINARY REFERENCE LABORATORY MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 122 VETERINARY REFERENCE LABORATORY MARKET FOR SHEEP & GOATS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 124 VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 125 US: BASIC ANNUAL EXPENSES FOR CATS AND DOGS, 2023 (USD)
TABLE 126 VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY HOSPITALS & CLINICS BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127 VETERINARY REFERENCE LABORATORY MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 128 VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER END USERS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130 VETERINARY REFERENCE LABORATORY MARKET, BY REGION,2023–2030 (USD MILLION)
TABLE 131 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 132 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 133 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 134 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 135 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 136 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 137 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 138 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 139 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 140 NORTH AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 141 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 142 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 143 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 144 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 145 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,BY END USER, 2023–2030 (USD MILLION)
TABLE 148 US: KEY MACROINDICATORS
TABLE 149 US: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 150 US: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 151 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 152 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 153 US: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 154 US: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 155 US: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 156 US: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 157 US: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 158 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 159 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 160 US: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,2023–2030 (USD MILLION)
TABLE 161 US: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,2023–2030 (USD MILLION)
TABLE 162 US: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163 US: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,BY TYPE, 2023–2030 (USD MILLION)
TABLE 164 US: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 165 CANADA: KEY MACROINDICATORS
TABLE 166 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 167 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 168 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 169 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 170 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 171 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 172 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 173 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 174 CANADA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 175 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 176 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 177 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 178 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 179 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 182 EUROPE: COMPANION POPULATION, BY COUNTRY, 2023 (MILLION)
TABLE 183 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 184 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 185 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 186 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 187 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 188 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 189 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 190 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 191 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 192 EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 193 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 194 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 195 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 196 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 197 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 200 GERMANY: KEY MACROINDICATORS
TABLE 201 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 202 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 203 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 204 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 205 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 206 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 207 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 208 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 209 GERMANY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 210 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 211 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 212 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 213 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 214 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 216 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 217 UK: KEY MACROINDICATORS
TABLE 218 UK: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 219 UK: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 220 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 221 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 222 UK: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 223 UK: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 224 UK: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 225 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 226 UK: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 227 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 228 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 229 UK: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,2023–2030 (USD MILLION)
TABLE 230 UK: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,2023–2030 (USD MILLION)
TABLE 231 UK: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232 UK: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,BY TYPE, 2023–2030 (USD MILLION)
TABLE 233 UK: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 234 FRANCE: KEY MACROINDICATORS
TABLE 235 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 236 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 237 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 238 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 239 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 240 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 241 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 242 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 243 RANCE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 244 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 245 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 246 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 247 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 248 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 251 ITALY: KEY MACROINDICATORS
TABLE 252 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 253 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 254 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 255 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 256 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 257 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 258 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 259 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 260 ITALY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 261 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 262 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 263 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,2023–2030 (USD MILLION)
TABLE 264 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,2023–2030 (USD MILLION)
TABLE 265 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 267 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 268 SPAIN: KEY MACROINDICATORS
TABLE 269 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 270 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 271 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 272 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 273 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 274 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 275 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 276 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 277 SPAIN: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 278 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 279 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 280 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,2023–2030 (USD MILLION)
TABLE 281 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,2023–2030 (USD MILLION)
TABLE 282 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 283 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 285 NETHERLANDS: KEY MACROINDICATORS
TABLE 286 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 287 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 288 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 289 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 290 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 291 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 292 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 293 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 294 NETHERLANDS: OTHER VETERINARY REFERENCE LABORATORY MARKET,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 295 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 296 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 297 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 298 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 299 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 301 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 302 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 303 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 304 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 305 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 306 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 307 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 308 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 309 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 310 REST OF EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 311 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 312 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 313 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET,BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 314 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 315 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 316 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 317 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET,BY END USER, 2023–2030 (USD MILLION)
TABLE 318 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 319 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 320 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 321 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 1 VETERINARY REFERENCE LABORATORY MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
TABLE 3 VETERINARY REFERENCE LABORATORY MARKET: MARKET ASSUMPTIONS
TABLE 4 VETERINARY REFERENCE LABORATORY MARKET: RISK ANALYSIS
TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES, 2009–2023
TABLE 6 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024,BY ANIMAL TYPE (MILLIONS)
TABLE 7 US: AVERAGE PREMIUMS PAID, 2020 VS. 2023
TABLE 8 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2023 (USD MILLION)
TABLE 9 VETERINARY REFERENCE LABORATORY MARKET: PORTER’S FIVE FORCES
TABLE 10 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORY PRODUCTS (%)
TABLE 11 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 MAJOR PATENTS IN VETERINARY REFERENCE LABORATORY MARKET
TABLE 16 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022–2024 (USD)
TABLE 17 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY SERVICES, BY REGION, 2022–2024 (USD)
TABLE 18 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022–2024 (USD)
TABLE 19 AVERAGE SELLING PRICE TREND OF MOLECULAR DIAGNOSTIC SERVICES,BY REGION, 2022–2024 (USD)
TABLE 20 AVERAGE SELLING PRICE TREND OF HAEMATOLOGY SERVICES, BY REGION, 2022–2024 (USD)
TABLE 21 AVERAGE SELLING PRICE TREND OF HISTOPATHOLOGY &CYTOLOGY SERVICES,BY REGION, 2022–2024 (USD)
TABLE 22 AVERAGE SELLING PRICE TREND OF URINALYSIS SERVICES, BY REGION,2022–2024 (USD)
TABLE 23 KEY CONFERENCES & EVENTS IN VETERINARY REFERENCE LABORATORY MARKET, JANUARY 2025–DECEMBER 2026
TABLE 24 KEY COMPANIES IMPLEMENTING AI IN VETERINARY REFERENCE LABORATORY MARKET
TABLE 25 VETERINARY REFERENCE LABORATORY PROVIDERS: ROLE IN ECOSYSTEM
TABLE 26 CASE STUDY 1: DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES
TABLE 27 CASE STUDY 2: IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING
TABLE 28 CASE STUDY 3: VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW
TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 30 KEY PRODUCT-RELATED TARIFF EFFECTIVE VETERINARY REFERENCE LABORATORY
TABLE 31 IMPACT OF US TARIFF ON CANADA
TABLE 32 IMPACT OF US TARIFF ON GERMANY AND UK
TABLE 33 IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA
TABLE 34 IMPACT OF US TARIFF ON MEXICO
TABLE 35 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 36 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY SERVICES
TABLE 37 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 39 CLINICAL CHEMISTRY MARKET FOR COMPANION ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 40 CLINICAL CHEMISTRY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
TABLE 42 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,BY SERVICE, 2023–2030 (USD MILLION)
TABLE 44 IMMUNODIAGNOSTICS MARKET FOR ELISA, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 45 IMMUNODIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46 IMMUNODIAGNOSTICS MARKET FOR ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47 OTHER IMMUNODIAGNOSTICS SERVICES MARKET, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 48 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,BY ANIMAL TYPE , 2023–2030 (USD MILLION)
TABLE 49 IMMUNODIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 50 IMMUNODIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 51 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC SERVICES
TABLE 52 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 54 MOLECULAR DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 55 MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 56 MOLECULAR DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57 OTHER MOLECULAR DIAGNOSTIC SERVICES MARKET, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 58 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 59 MOLECULAR DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60 MOLECULAR DIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61 KEY PLAYERS PROVIDING HAEMATOLOGY SERVICES
TABLE 62 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 64 HAEMATOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 65 HAEMATOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 66 KEY PLAYERS PROVIDING URINALYSIS TECHNOLOGIES
TABLE 67 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 69 URINALYSIS MARKET FOR COMPANION ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 70 URINALYSIS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 71 KEY PLAYERS PROVIDING HISTOPATHOLOGY & CYTOLOGY SERVICES
TABLE 72 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 74 HISTOPATHOLOGY & CYTOLOGY MARKET FOR COMPANION ANIMALS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 75 HISTOPATHOLOGY & CYTOLOGY MARKET FOR LIVESTOCK ANIMALS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76 KEY PLAYERS PROVIDING MICROBIOLOGY SERVICES
TABLE 77 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 79 MICROBIOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 80 MICROBIOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 81 KEY PLAYERS PROVIDING OTHER VETERINARY REFERENCE LABORATORY SERVICES
TABLE 82 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 84 OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85 OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,2023–2030 (USD MILLION)
TABLE 87 KEY PLAYERS PROVIDING CLINICAL PATHOLOGY SERVICES
TABLE 88 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL PATHOLOGY,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89 KEY PLAYERS PROVIDING BACTERIOLOGY SERVICES
TABLE 90 VETERINARY REFERENCE LABORATORY MARKET FOR BACTERIOLOGY,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91 KEY PLAYERS PROVIDING VIROLOGY SERVICES
TABLE 92 VETERINARY REFERENCE LABORATORY MARKET FOR VIROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93 KEY PLAYERS PROVIDING PARASITOLOGY SERVICES
TABLE 94 VETERINARY REFERENCE LABORATORY MARKET FOR PARASITOLOGY,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95 KEY PLAYERS PROVIDING PRODUCTIVITY TESTING SERVICES
TABLE 96 VETERINARY REFERENCE LABORATORY MARKET FOR PRODUCTIVITY TESTING,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97 KEY PLAYERS PROVIDING PREGNANCY TESTING SERVICES
TABLE 98 VETERINARY REFERENCE LABORATORY MARKET FOR PREGNANCY TESTING,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99 KEY PLAYERS PROVIDING TOXICOLOGY TESTING SERVICES
TABLE 100 VETERINARY REFERENCE LABORATORY MARKET FOR TOXICOLOGY TESTING,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 101 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER APPLICATIONS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,2023–2030 (USD MILLION)
TABLE 103 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR COMPANION ANIMALS
TABLE 104 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS,BY TYPE, 2023–2030 (USD MILLION)
TABLE 105 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR DOGS
TABLE 107 VETERINARY REFERENCE LABORATORY MARKET FOR DOGS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 108 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR CATS
TABLE 109 VETERINARY REFERENCE LABORATORY MARKET FOR CATS, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 110 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR HORSES
TABLE 111 VETERINARY REFERENCE LABORATORY MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR LIVESTOCK ANIMALS
TABLE 114 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,BY TYPE, 2023–2030 (USD MILLION)
TABLE 115 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 116 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR CATTLE
TABLE 117 VETERINARY REFERENCE LABORATORY MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 118 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR SWINE
TABLE 119 VETERINARY REFERENCE LABORATORY MARKET FOR SWINE, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 120 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR POULTRY
TABLE 121 VETERINARY REFERENCE LABORATORY MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 122 VETERINARY REFERENCE LABORATORY MARKET FOR SHEEP & GOATS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 124 VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 125 US: BASIC ANNUAL EXPENSES FOR CATS AND DOGS, 2023 (USD)
TABLE 126 VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY HOSPITALS & CLINICS BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127 VETERINARY REFERENCE LABORATORY MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 128 VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER END USERS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130 VETERINARY REFERENCE LABORATORY MARKET, BY REGION,2023–2030 (USD MILLION)
TABLE 131 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 132 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 133 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 134 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 135 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 136 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 137 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 138 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 139 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 140 NORTH AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 141 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 142 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 143 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 144 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 145 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,BY END USER, 2023–2030 (USD MILLION)
TABLE 148 US: KEY MACROINDICATORS
TABLE 149 US: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 150 US: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 151 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 152 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 153 US: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 154 US: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 155 US: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 156 US: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 157 US: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 158 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 159 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 160 US: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,2023–2030 (USD MILLION)
TABLE 161 US: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,2023–2030 (USD MILLION)
TABLE 162 US: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163 US: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,BY TYPE, 2023–2030 (USD MILLION)
TABLE 164 US: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 165 CANADA: KEY MACROINDICATORS
TABLE 166 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 167 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 168 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 169 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 170 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 171 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 172 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 173 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 174 CANADA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 175 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 176 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 177 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 178 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 179 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 182 EUROPE: COMPANION POPULATION, BY COUNTRY, 2023 (MILLION)
TABLE 183 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY,2023–2030 (USD MILLION)
TABLE 184 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 185 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 186 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 187 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 188 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 189 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 190 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 191 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 192 EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 193 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 194 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 195 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 196 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 197 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 200 GERMANY: KEY MACROINDICATORS
TABLE 201 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 202 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 203 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 204 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 205 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 206 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 207 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 208 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 209 GERMANY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 210 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 211 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 212 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 213 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 214 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 216 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 217 UK: KEY MACROINDICATORS
TABLE 218 UK: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 219 UK: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 220 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 221 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 222 UK: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 223 UK: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 224 UK: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 225 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 226 UK: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 227 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 228 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 229 UK: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,2023–2030 (USD MILLION)
TABLE 230 UK: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,2023–2030 (USD MILLION)
TABLE 231 UK: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232 UK: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,BY TYPE, 2023–2030 (USD MILLION)
TABLE 233 UK: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 234 FRANCE: KEY MACROINDICATORS
TABLE 235 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 236 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 237 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 238 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 239 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 240 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 241 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 242 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 243 RANCE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 244 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 245 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 246 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 247 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 248 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 251 ITALY: KEY MACROINDICATORS
TABLE 252 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 253 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 254 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 255 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 256 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 257 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 258 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 259 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 260 ITALY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 261 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 262 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 263 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,2023–2030 (USD MILLION)
TABLE 264 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,2023–2030 (USD MILLION)
TABLE 265 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 267 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 268 SPAIN: KEY MACROINDICATORS
TABLE 269 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,2023–2030 (USD MILLION)
TABLE 270 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 271 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 272 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 273 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 274 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 275 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 276 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 277 SPAIN: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 278 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 279 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 280 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,2023–2030 (USD MILLION)
TABLE 281 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,2023–2030 (USD MILLION)
TABLE 282 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 283 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 285 NETHERLANDS: KEY MACROINDICATORS
TABLE 286 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 287 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 288 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 289 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 290 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 291 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 292 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 293 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 294 NETHERLANDS: OTHER VETERINARY REFERENCE LABORATORY MARKET,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 295 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 296 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 297 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 298 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 299 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 301 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 302 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 303 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 304 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 305 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 306 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 307 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 308 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 309 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 310 REST OF EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET,BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 311 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 312 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 313 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET,BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 314 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 315 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 316 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 317 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET,BY END USER, 2023–2030 (USD MILLION)
TABLE 318 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 319 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023–2030 (USD MILLION)
TABLE 320 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 321 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 VETERINARY REFERENCE LABORATORY MARKET SEGMENTATION
FIGURE 2 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL SCOPE
FIGURE 3 VETERINARY REFERENCE LABORATORY MARKET: YEARS CONSIDERED
FIGURE 4 VETERINARY REFERENCE LABORATORY MARKET: RESEARCH DESIGN
FIGURE 5 VETERINARY REFERENCE LABORATORY MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 6 VETERINARY REFERENCE LABORATORY MARKET: KEY PRIMARY SOURCES
FIGURE 7 VETERINARY REFERENCE LABORATORY MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 8 VETERINARY REFERENCE LABORATORY MARKET: KEY INDUSTRY INSIGHTS
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
FIGURE 11 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 12 VETERINARY REFERENCE LABORATORY MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 13 VETERINARY REFERENCE LABORATORY MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR IDEXX LABORATORIES, INC. (2024)
FIGURE 14 REVENUE ANALYSIS OF TOP FIVE COMPANIES IN VETERINARY REFERENCE LABORATORY MARKET (2024)
FIGURE 15 VETERINARY DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
FIGURE 16 VETERINARY REFERENCE LABORATORY MARKET: TOP-DOWN APPROACH
FIGURE 17 VETERINARY REFERENCE LABORATORY MARKET: BOTTOM-UP APPROACH
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VETERINARY REFERENCE LABORATORY MARKET (2025–2030)
FIGURE 19 VETERINARY REFERENCE LABORATORY MARKET: CAGR PROJECTIONS
FIGURE 20 VETERINARY REFERENCE LABORATORY MARKET: DATA TRIANGULATION METHODOLOGY
FIGURE 21 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2025 VS. 2030 (USD MILLION)
FIGURE 22 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 23 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 24 COMPANION ANIMALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 25 LIVESTOCK ANIMALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 26 VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 27 GEOGRAPHIC SNAPSHOT OF VETERINARY REFERENCE LABORATORY MARKET
FIGURE 28 INCREASING INCIDENCE OF CHRONIC CONDITIONS TO FUEL MARKET GROWTH
FIGURE 29 CHINA AND CONSUMABLES COMMANDED LARGEST MARKET SHARE IN 2024
FIGURE 30 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 31 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
FIGURE 32 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES FROM 2025 TO 2030
FIGURE 33 VETERINARY REFERENCE LABORATORY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 34 EUROPE: PET POPULATION (DOGS VS. CATS), 2021–2023 (MILLION)
FIGURE 35 US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD)
FIGURE 36 VETERINARY REFERENCE LABORATORY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 37 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORIES
FIGURE 38 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 39 NUMBER OF GRANTED PATENT APPLICATIONS IN VETERINARY REFERENCE LABORATORY MARKET (JANUARY 2014–SEPTEMBER 2025)
FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY REFERENCE LABORATORY PATENTS (JANUARY 2014–OCTOBER 2025)
FIGURE 41 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC AND URINALYSIS SERVICES, BY KEY PLAYER (2024)
FIGURE 42 AVERAGE SELLING PRICE OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION (2024)
FIGURE 43 AI-USE CASES IN VETERINARY REFERENCE LABORATORY MARKET
FIGURE 44 VETERINARY REFERENCE LABORATORY MARKET: ECOSYSTEM MAP
FIGURE 45 VETERINARY REFERENCE LABORATORY MARKET: VALUE CHAIN ANALYSIS
FIGURE 46 FUNDING AND NUMBER OF DEALS IN VETERINARY REFERENCE LABORATORY MARKET, 2020-2024 (USD MILLION)
FIGURE 47 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ CUSTOMERS IN VETERINARY REFERENCE LABORATORY MARKET
FIGURE 48 ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, DEVELOPING VS. DEVELOPED COUNTRIES, 2020–2030
FIGURE 49 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 50 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT
FIGURE 51 US: POPULATION OF DOGS, 2012–2022 (MILLION)
FIGURE 52 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT
FIGURE 53 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET (2020?2024)
FIGURE 54 RANKING OF KEY PLAYERS IN GLOBAL VETERINARY SOFTWARE MARKET, 2024
FIGURE 55 GLOBAL VETERINARY REFERENCE LABORATORY MARKET SHARE ANALYSIS (2024)
FIGURE 56 US: VETERINARY REFERENCE LABORATORY MARKET SHARE ANALYSIS, BY KEY PLAYER (2024)
FIGURE 57 VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 58 VETERINARY REFERENCE LABORATORY MARKET: COMPANY FOOTPRINT
FIGURE 59 VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 60 VETERINARY REFERENCE LABORATORY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 61 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET, 2022?2024
FIGURE 62 EV/EBITDA OF KEY VENDORS
FIGURE 63 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 64 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 65 ZOETIS SERVICES LLC: COMPANY SNAPSHOT
FIGURE 66 CVS (UK) LIMITED: COMPANY SNAPSHOT
FIGURE 1 VETERINARY REFERENCE LABORATORY MARKET SEGMENTATION
FIGURE 2 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL SCOPE
FIGURE 3 VETERINARY REFERENCE LABORATORY MARKET: YEARS CONSIDERED
FIGURE 4 VETERINARY REFERENCE LABORATORY MARKET: RESEARCH DESIGN
FIGURE 5 VETERINARY REFERENCE LABORATORY MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 6 VETERINARY REFERENCE LABORATORY MARKET: KEY PRIMARY SOURCES
FIGURE 7 VETERINARY REFERENCE LABORATORY MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 8 VETERINARY REFERENCE LABORATORY MARKET: KEY INDUSTRY INSIGHTS
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
FIGURE 11 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 12 VETERINARY REFERENCE LABORATORY MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 13 VETERINARY REFERENCE LABORATORY MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR IDEXX LABORATORIES, INC. (2024)
FIGURE 14 REVENUE ANALYSIS OF TOP FIVE COMPANIES IN VETERINARY REFERENCE LABORATORY MARKET (2024)
FIGURE 15 VETERINARY DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
FIGURE 16 VETERINARY REFERENCE LABORATORY MARKET: TOP-DOWN APPROACH
FIGURE 17 VETERINARY REFERENCE LABORATORY MARKET: BOTTOM-UP APPROACH
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VETERINARY REFERENCE LABORATORY MARKET (2025–2030)
FIGURE 19 VETERINARY REFERENCE LABORATORY MARKET: CAGR PROJECTIONS
FIGURE 20 VETERINARY REFERENCE LABORATORY MARKET: DATA TRIANGULATION METHODOLOGY
FIGURE 21 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2025 VS. 2030 (USD MILLION)
FIGURE 22 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 23 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 24 COMPANION ANIMALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 25 LIVESTOCK ANIMALS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 26 VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 27 GEOGRAPHIC SNAPSHOT OF VETERINARY REFERENCE LABORATORY MARKET
FIGURE 28 INCREASING INCIDENCE OF CHRONIC CONDITIONS TO FUEL MARKET GROWTH
FIGURE 29 CHINA AND CONSUMABLES COMMANDED LARGEST MARKET SHARE IN 2024
FIGURE 30 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 31 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
FIGURE 32 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES FROM 2025 TO 2030
FIGURE 33 VETERINARY REFERENCE LABORATORY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 34 EUROPE: PET POPULATION (DOGS VS. CATS), 2021–2023 (MILLION)
FIGURE 35 US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD)
FIGURE 36 VETERINARY REFERENCE LABORATORY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 37 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORIES
FIGURE 38 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 39 NUMBER OF GRANTED PATENT APPLICATIONS IN VETERINARY REFERENCE LABORATORY MARKET (JANUARY 2014–SEPTEMBER 2025)
FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY REFERENCE LABORATORY PATENTS (JANUARY 2014–OCTOBER 2025)
FIGURE 41 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC AND URINALYSIS SERVICES, BY KEY PLAYER (2024)
FIGURE 42 AVERAGE SELLING PRICE OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION (2024)
FIGURE 43 AI-USE CASES IN VETERINARY REFERENCE LABORATORY MARKET
FIGURE 44 VETERINARY REFERENCE LABORATORY MARKET: ECOSYSTEM MAP
FIGURE 45 VETERINARY REFERENCE LABORATORY MARKET: VALUE CHAIN ANALYSIS
FIGURE 46 FUNDING AND NUMBER OF DEALS IN VETERINARY REFERENCE LABORATORY MARKET, 2020-2024 (USD MILLION)
FIGURE 47 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ CUSTOMERS IN VETERINARY REFERENCE LABORATORY MARKET
FIGURE 48 ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, DEVELOPING VS. DEVELOPED COUNTRIES, 2020–2030
FIGURE 49 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 50 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT
FIGURE 51 US: POPULATION OF DOGS, 2012–2022 (MILLION)
FIGURE 52 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT
FIGURE 53 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET (2020?2024)
FIGURE 54 RANKING OF KEY PLAYERS IN GLOBAL VETERINARY SOFTWARE MARKET, 2024
FIGURE 55 GLOBAL VETERINARY REFERENCE LABORATORY MARKET SHARE ANALYSIS (2024)
FIGURE 56 US: VETERINARY REFERENCE LABORATORY MARKET SHARE ANALYSIS, BY KEY PLAYER (2024)
FIGURE 57 VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 58 VETERINARY REFERENCE LABORATORY MARKET: COMPANY FOOTPRINT
FIGURE 59 VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 60 VETERINARY REFERENCE LABORATORY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 61 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET, 2022?2024
FIGURE 62 EV/EBITDA OF KEY VENDORS
FIGURE 63 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 64 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 65 ZOETIS SERVICES LLC: COMPANY SNAPSHOT
FIGURE 66 CVS (UK) LIMITED: COMPANY SNAPSHOT
